Time to Act - Has Judgment Day Arrived for Counterfeit Drugs?
An Introduction to The Challenges Presented By Product Codification & Serialization In The Pharmaceutical Sector
It is well recognized that the counterfeiting of pharmaceutical drugs and medical devices is a real and constant threat to patient safety. It is a global issue that affects all of us. It doesn’t recognize borders or trade agreements and its supply chain is fast to react to new opportunities and, in particular, weaknesses in the legitimate production and supply of medicines and devices.
Read our white paper, “Time to Act – Has Judgment Day Arrived for Counterfeit Drugs?” to learn about the differences in approach between the US Electronic Pedigree (ePedigree) based approach and the European style mass serialization approach.